轻度自主皮质醇分泌患者椎体骨折风险增加
该横断面与纵向研究利用意大利4个内分泌中心的回顾性数据,纳入444例(横断面)和126例(纵向,随访24.9±5.3个月)肾上腺意外瘤患者,评估轻度自主皮质醇分泌(MACS)与椎体骨折的关系。结果显示MACS患者现患椎体骨折比例更高(62.6% vs 22.9%,P<.001),新发椎体骨折风险也更高(RR 4.561,95%CI 1.600-13.003,P=.005)。
要点
- MACS患者现患椎体骨折比例为62.6%,无MACS者为22.9%(P<.001)。
- MACS与新发椎体骨折相关(RR 4.561,95%CI 1.600-13.003,P=.005)。
- MACS与现患椎体骨折的关联独立于年龄、BMI、性别、腰椎骨密度和2型糖尿病。
核心结论
- 患有肾上腺意外瘤和MACS的男女患者椎体骨折风险更高。
研究设计与样本
- 横断面与纵向研究,使用来自意大利4个内分泌单位的回顾性数据。
- 横断面臂纳入444例患者,纵向臂纳入126例患者,随访24.9±5.3个月。
- 根据1 mg地塞米松试验后血清皮质醇(F-1mgDST)>1.8 µg/dL(50 nmol/L)定义MACS-yes,否则为MACS-no。
主要发现
- 横断面臂中MACS-yes组214例、MACS-no组230例,MACS-yes组现患椎体骨折比例为62.6%,高于MACS-no组的22.9%(P<.001)。
- 横断面臂中MACS与现患椎体骨折相关(比值比5.203,95%CI 3.361-8.055,P<.001;相对风险RR 2.07),独立于年龄、体质指数、性别分布、腰椎骨密度和2型糖尿病。
- 纵向臂中MACS-no组66例、MACS-yes组60例,MACS-no组新发椎体骨折比例为36.4%,高于MACS-yes组的10.0%(P<.001)。
- 纵向臂中MACS与新发椎体骨折相关(RR 4.561,95%CI 1.600-13.003,P=.005),独立于年龄、腰椎骨密度、性别分布、现患椎体骨折和2型糖尿病。
关键数值与推荐
- MACS定义:1 mg地塞米松试验后血清皮质醇>1.8 µg/dL(50 nmol/L)。
- 横断面臂现患椎体骨折:MACS-yes组62.6% vs MACS-no组22.9%(P<.001)。
- 横断面臂MACS与现患椎体骨折的OR为5.203(95%CI 3.361-8.055,P<.001),RR为2.07。
- 纵向臂新发椎体骨折:MACS-yes组10.0% vs MACS-no组36.4%(P<.001),MACS与新发椎体骨折的RR为4.561(95%CI 1.600-13.003,P=.005)。
临床怎么用
- 原文未据此给出推荐。
- 原文结论为:患有肾上腺意外瘤和MACS的男女患者椎体骨折风险更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The risk of vertebral fractures (VFx) in patients with adrenal incidentalomas (AI) and mild autonomous cortisol secretion (MACS) is debated. OBJECTIVE: To evaluate the VFx prevalence and incidence in patients with AI and MACS. METHODS: This cross-sectional and longitudinal study using retrospective data from 4 Italian endocrinology units included 444 patients (cross-sectional arm) and 126 patients (longitudinal arm, 24.9 ± 5.3 months follow-up) to evaluate prevalent and incident VFx, respectively, in patients with MACS (MACS-yes) and without MACS (MACS-no). The main outcome measures were serum cortisol after a 1-mg dexamethasone test (F-1mgDST), bone mineral density (BMD) by dual-energy x-ray absorptiometry at spine (LS) and femur (FN), and VFx presence by x-ray. RESULTS: Cross-sectional arm: 214 and 230 patients were MACS-yes and MACS-no, respectively, based on F-1mgDST >1.8 µg/dL (50 nmol/L). Patients with MACS had higher VFx prevalence (62.6%) than those without MACS (22.9%, P < .001); MACS was associated with prevalent VFx (odds ratio, 5.203; 95% CI, 3.361-8.055; P < .001; relative risk [RR] 2.07), regardless of age, body mass index, gender distribution, LS-BMD, and presence of type 2 diabetes mellitus (T2D). Longitudinal arm: 66 and 60 patients were MACS-no and MACS-yes, respectively. Patients without MACS showed higher number of incident VFx (36.4%) than patients without MACS (10.0%, P < .001); MACS was associated with the presence of an incident VFx (RR 4.561; 95% CI, 1.600-13.003; P = .005) regardless of age, LS-BMD, gender distribution, presence of prevalent VFx, and T2D. Results were confirmed in women and men when separately evaluated. CONCLUSION: Women and men with AI and MACS are at higher risk of VFx.
引用
- Favero V, Eller-Vainicher C, Morelli V, et al. Increased Risk of Vertebral Fractures in Patients With Mild Autonomous Cortisol Secretion. J Clin Endocrinol Metab. 2024. PMID: 37738555. doi:10.1210/clinem/dgad560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。